Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

Clinical trial NCT04925960 · TERMINATED

Trial details

NCT number: NCT04925960
Sponsor: Maggie's Pearl, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pmm2-CDG Phosphomannomutase 2 Deficiency Phosphomannomutase 2 Congenital Disorder of Glycosylation Phosphomannomutase II Congenital Disorder of Glycosylation Phosphomannomutase II Deficiency

Start date: 2022-11-10
Primary completion: 2025-02-28
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.